Artara Therapeutics Inc (TARA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.17 +0.03 (+0.72%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.17 unch (unch) 16:00 ET
for Tue, Apr 15th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TARA | NBTX | CATX | ||
| Company | Artara Therapeutics Inc | Nanobiotix S.A. ADR | Perspective Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 4.18 | 3.39 | 2.02 | ||
| High | 4.30 | 3.53 | 2.11 | ||
| Low | 4.10 | 3.30 | 2.00 | ||
| Last | 4.17 | 3.41 | 2.09 | ||
| Change | +0.03 | +0.08 | +0.04 | ||
| % Change | +0.72% | +2.40% | +1.95% | ||
| Volume | 326,600 | 13,200 | 413,900 | ||
| 20-Day Average Volume | 271,225 | 12,445 | 930,855 | ||
| Previous Close | 4.14 | 3.33 | 2.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.26 | 3.44 | 2.12 | ||
| 20-Day Raw Stochastic | 49.44% | 40.00% | 48.04% | ||
| 20-Day Relative Strength | 50.01% | 49.58% | 41.57% | ||
| Weighted Alpha | -7.50 | -36.75 | -76.03 | ||
| Today's Opinion | 32% Buy | 56% Sell | 100% Sell | ||
| Previous Opinion | 24% Buy | 72% Sell | 100% Sell | ||
| Last Month's Opinion | 48% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.20% since 04/08/25 | +12.91% since 04/08/25 | +22.22% since 04/08/25 | ||
| Low | 3.54 on 04/09/25 | 2.99 on 04/09/25 | 1.60 on 04/09/25 | ||
| High | 4.30 on 04/15/25 | 3.53 on 04/15/25 | 2.11 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -3.25% since 03/14/25 | +5.08% since 03/14/25 | -19.31% since 03/14/25 | ||
| Low | 3.54 on 04/09/25 | 2.99 on 04/09/25 | 1.60 on 04/09/25 | ||
| High | 4.81 on 03/25/25 | 4.04 on 03/19/25 | 2.75 on 03/17/25 | ||
| 3-Month | |||||
| %Chg | -10.71% since 01/15/25 | +16.78% since 01/15/25 | -36.09% since 01/15/25 | ||
| Low | 3.19 on 03/04/25 | 2.93 on 01/16/25 | 1.60 on 04/09/25 | ||
| High | 5.26 on 02/04/25 | 4.33 on 02/14/25 | 4.24 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | +132.96% since 10/15/24 | -29.84% since 10/15/24 | -83.36% since 10/15/24 | ||
| Low | 1.77 on 10/18/24 | 2.76 on 12/05/24 | 1.60 on 04/09/25 | ||
| High | 10.48 on 12/05/24 | 5.07 on 10/23/24 | 13.19 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 152,215 | 156,953 | 151,807 | ||
| Shares Outstanding, K | 36,767 | 47,133 | 74,052 | ||
| Annual Sales | 0 | -7,780,000 | 1,450,000 | ||
| Annual Net Income | -44,600,000 | -73,730,000 | -79,280,000 | ||
| Last Quarter Sales | 0 | N/A | 230,000 | ||
| Last Quarter Net Income | -12,770,000 | N/A | -40,170,000 | ||
| 60-Month Beta | 1.60 | 0.26 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 03/05/25 | N/A | -0.21 on 11/12/24 | ||
| Latest Earnings Date | 05/01/25 | 04/02/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||